235 related articles for article (PubMed ID: 33692622)
1. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
[TBL] [Abstract][Full Text] [Related]
2. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
3. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid
Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G
Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257
[TBL] [Abstract][Full Text] [Related]
5. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
6. Design, In Silico Modelling, and Functionality Theory of Novel Folate Receptor Targeted Rutin Encapsulated Folic Acid Conjugated Keratin Nanoparticles for Effective Cancer Treatment.
Kunjiappan S; Panneerselvam T; Govindaraj S; Parasuraman P; Baskararaj S; Sankaranarayanan M; Arunachalam S; Babkiewicz E; Jeyakumar A; Lakshmanan M
Anticancer Agents Med Chem; 2019; 19(16):1966-1982. PubMed ID: 31267878
[TBL] [Abstract][Full Text] [Related]
7. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.
Sharma R; Yadav V; Jha S; Dighe S; Jain S
Carbohydr Polym; 2024 Aug; 338():122196. PubMed ID: 38763723
[TBL] [Abstract][Full Text] [Related]
9. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery.
Wang D; Chen W; Li H; Huang G; Zhou Y; Wang Y; Wan W; You B; Liu Y; Zhang X
Int J Pharm; 2020 Jul; 585():119456. PubMed ID: 32492507
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy.
Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170
[TBL] [Abstract][Full Text] [Related]
11. Preparation and In Vitro/In Vivo Characterization of Polymeric Nanoparticles Containing Methotrexate to Improve Lymphatic Delivery.
Jang JH; Jeong SH; Lee YB
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284483
[TBL] [Abstract][Full Text] [Related]
12. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
13. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
[TBL] [Abstract][Full Text] [Related]
14. Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate-mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects.
Fan Z; Wang Y; Xiang S; Zuo W; Huang D; Jiang B; Sun H; Yin W; Xie L; Hou Z
J Mater Chem B; 2020 Mar; 8(9):1922-1934. PubMed ID: 32052817
[TBL] [Abstract][Full Text] [Related]
15. Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo.
Jin H; Pi J; Yang F; Jiang J; Wang X; Bai H; Shao M; Huang L; Zhu H; Yang P; Li L; Li T; Cai J; Chen ZW
Sci Rep; 2016 Jul; 6():30782. PubMed ID: 27469490
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
17. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
[TBL] [Abstract][Full Text] [Related]
18. In vitro control release, cytotoxicity assessment and cellular uptake of methotrexate loaded liquid-crystalline folate nanocarrier.
Misra R; Upadhyay M; Perumal V; Mohanty S
Biomed Pharmacother; 2015 Feb; 69():102-10. PubMed ID: 25661345
[TBL] [Abstract][Full Text] [Related]
19. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
20. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
